KEYNOTE-689: A Phase 3 Study of Neoadjuvant and Adjuvant Pembrolizumab Plus Standard of Care (SOC) in Resectable, Locally Advanced (LA) Head and Neck Squamous Cell Carcinoma (HNSCC). Issue 1 (January 2023)

• Record Type: Journal Article
• Authors: Klochikhin, Arkadiy; Haddad, Robert I.; Meirovitz, Amichay; Safina, Sufia; Brana, Irene; Le Tourneau, Christophe; Uppaluri, Ravindra; Lee, Nancy Y.; Cohen, Ezra E.W.; Chernock, Rebecca; Westra, William; Liu, Hong; Gumuscu, Burak; Benjamin, Kimberly; Adkins, Douglas
• Is Part Of: European journal of surgical oncology. Volume 49:Issue 1(2023)
• Page Start: e9
• Publication Date: 2023-01
• Subjects: Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2022.11.056
• Languages: English
• ISSNs: 0748-7983